Supplementary Table 8 from Ciliated Cells Drive Critical STING-Mediated Tumor Suppression in the Fallopian Tube Epithelium

Jose A. Colina, María Sol Recouvreux, Alexander M. Sobeck, Benjamin K. Johnson, Yinzhi Lin, Sreeja C. Sekhar, Rita A. Avelar, Gabriela Rivera-Gonzalez, Yali Zhai, Harini Ram, amber fatima, Paula DiBenedetto, Justin Baldassarre, Grace McIntyre, Jessica Teitel, Michele Dziubinski, Noah Puleo, Jane Miglo, Karan Bedi, Hui Shen, Dafydd G. Thomas, Jutta Huvila, Dawn R. Cochrane, Ronny Drapkin, Yu L. Lei, Joanna E. Burdette, Stephanie L. Skala, David G. Huntsman, Kathleen R. Cho, Sandra Oršulić, Analisa DiFeo
In: American Association for Cancer Research · 2026 · doi:10.1158/0008-5472.32675390 · W7164828466
supplementary-materials OA: gold CC0
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-09 ⓘ

This study quantified STING immunostaining in healthy fallopian tube epithelium, epithelium from patients with endometriosis or chronic salpingitis, and early-stage high-grade serous ovarian cancer.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Quantification of IHC staining for STING conducted on a tumor microarray including cores from healthy FT, FT from patients with gynecological inflammation resulting from endometriosis or chronic salpingitis, and Stage I/Stage II HGSC

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-09-06T06:08:46.149282+00:00
License: CC0 · commercial use OK